-
KU-55933 (ATM Kinase Inhibitor) Assay Guide
2026-09-19
This scenario-based guide explains how KU-55933 (ATM Kinase Inhibitor), SKU A4605, can help researchers interpret viability, proliferation, metabolism, and cell-cycle data in ATM-focused experiments. It covers assay design, formulation, protocol optimization, result interpretation, and practical reagent-selection criteria.
-
N4-Acetylcytidine Workflow for RNA Studies
2026-09-19
N4-Acetylcytidine provides a chemically defined acetylated cytidine standard for dissecting RNA modification chemistry, nucleotide metabolism, and enzyme specificity. This workflow connects structural evidence on ASCH-domain proteins with practical controls for RNA epigenetics research, analytical assays, and RNA structure-function analysis.
-
Palomid 529: A Translational Strategy for ESCC
2026-09-18
Palomid 529 (P529) offers a mechanistically disciplined way to test whether PI3K/Akt/mTOR pathway dependence links RCN2-driven metastasis and cisplatin resistance in esophageal squamous cell carcinoma. This thought-leadership analysis translates the RCN2–UBR5–PPP2CA findings into experimental, biomarker, radiotherapy enhancement, and development strategies.
-
MLN4924 HCl salt: NAE Inhibition Workflows
2026-09-18
MLN4924 HCl salt provides a controllable way to interrogate NEDD8-dependent cullin-RING ligase activity, protein turnover, and cell-death signaling. This workflow connects pathway inhibition with the viral RIPK3-degradation mechanism reported in Immunity while emphasizing assay controls, timing, and troubleshooting.
-
Carvedilol Phosphate in Hepatic IRI Research
2026-09-17
Carvedilol Phosphate offers a solvent-aware way to perturb adrenergic signaling while researchers track hepatocyte–macrophage communication in ischemia–reperfusion injury models. This guide connects formulation, hypoxia–reoxygenation workflows, metabolite analysis, and Arrb2-focused validation without presenting a research compound as a treatment.
-
Phalloidin B7678: F-Actin Workflow Guide
2026-09-17
Phalloidin (B7678) provides high-affinity actin filament stabilization for endpoint cytoskeleton visualization in fixed, permeabilized, or cell-free samples. It should not be used for live-cell imaging or experiments that require reversible actin binding and undisturbed cytoskeletal dynamics.
-
Oltipraz Workflow for Nrf2 Liver Research
2026-09-16
Oltipraz provides a defined small-molecule perturbation for studying Nrf2-driven phase II detoxification, oxidative-stress defense, and ferroptosis-related readouts. This workflow uses findings from recent MASLD research to help investigators separate direct Nrf2 effects from the broader, multi-component activity of Qushi Huoxue ointment.
-
Gefitinib Sensitization of Cisplatin-Resistant NSCLC
2026-09-15
The reference study identifies abnormal EGFR phosphorylation as a potential off-target mechanism of Cisplatin resistance in wild-type EGFR non-small cell lung cancer. Using paired parental and resistant cell models plus H358R xenografts, the authors show that gefitinib can enhance Cisplatin-associated growth suppression and apoptosis, supporting EGFR inhibition as a preclinical combination strategy rather than as mutation-directed monotherapy.
-
Cy5-UTP: From RNA Labeling to XIST–SPEN Mechanism
2026-09-14
Cy5-UTP can do more than make RNA visible. When integrated with the structural biology of XIST A-repeat binding to SPEN, Cyanine 5-uridine triphosphate supports a mechanism-first workflow for RNA probe synthesis, fluorescence in situ hybridization, biochemical validation, and translational assay design.
-
H2S Deficiency and ER Stress in Diabetic Cardiomyopathy
2026-09-14
The reference study identifies reduced endogenous hydrogen sulfide production as a mechanistically relevant feature of lipotoxic injury in diabetic cardiomyopathy. By combining patient samples, a diabetic rat model, and palmitate-treated cardiomyocytes, it links H2S deficiency with endoplasmic reticulum stress and shows that H2S donation can reduce myocardial injury-related phenotypes.
-
How Mixing Shapes mRNA LNP Performance
2026-09-13
This Nature Communications study isolates primary mixing as a major determinant of mRNA lipid nanoparticle physicochemistry and biological performance. By comparing ten mixing approaches under otherwise controlled formulation conditions, it shows why manually prepared or laminar-mixed particles may not predict materials produced with turbulent-flow equipment at manufacturing scale.
-
Ibrutinib (PCI-32765): BTK Research Workflows
2026-09-12
Build reproducible B-cell receptor signaling assays with Ibrutinib (PCI-32765), from acute BTK pathway readouts to longer-term viability studies. The workflow also shows how ATRX-stratified glioma findings can inform experimental design without overstating evidence for BTK inhibition outside B-cell models.
-
Selonsertib (GS-4997) in Kidney Fibrosis Workflows
2026-09-12
Selonsertib (GS-4997) provides a selective way to test whether ASK1-driven oxidative stress contributes to renal inflammation and tubulointerstitial fibrosis. This practical guide connects the lupus nephritis reference model with cell-based pathway assays, formulation controls, and decision points for diabetic kidney disease research.
-
Fructus Rubi Glycosides in Benign Prostatic Hyperplasia
2026-09-11
The reference study evaluates a diterpene glycoside extract from Fructus Rubi as a multitarget intervention for benign prostatic hyperplasia, combining androgen-pathway modulation with effects on TGF-β/Smad-associated remodeling. Its integrated cell, rat, and target-stability design provides a mechanistic framework for interpreting how botanical constituents may reduce prostate-cell proliferation and pathological enlargement.
-
Silybin A in Metabolic Liver Research
2026-09-11
Silybin A offers a defined chemical tool for studying oxidative stress, inflammation, and hepatoprotective signaling. This article connects Silymarin research with adipose-targeted CRISPRi while providing an assay framework that separates genetic causality from small-molecule response.